Actively Recruiting
Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome With or Without Biofeedback
Led by Université du Québec a Montréal · Updated on 2025-07-08
150
Participants Needed
1
Research Sites
241 weeks
Total Duration
On this page
Sponsors
U
Université du Québec a Montréal
Lead Sponsor
C
Ciusss de L'Est de l'Île de Montréal
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare the effectiveness of CoPs therapy with or without the therapeutic component of biofeedback in treating tics in Tourette Syndrome with emerging young adults. Hypotheses: 1. The CoPs+Biofeedback treatment will improve the severity of tics (YGTSS) and the Clinical Global Impression, surpassing the clinical significance threshold of CoPs treatment alone. 2. We expect that the identified variables (psychosocial, neurocognitive, biological) will predict the improvement of tics. Researchers will compare if the biofeedback treatment will improve the severity of tics. * In the pre-test, participants will undergo two interviews, each lasting 3 hours. These interviews will assess (through a battery of tests) the severity of tics as well as the psychosocial, biological, and neurocognitive aspects of functioning. A general assessment of intelligence and executive functions will also be conducted. * They will next attend 10 to 12 therapy sessions, with or without biofeedback. (The biofeedback component is explained in more detail in the ''Study Design'' section). * The post-test follow-ups consist of two evaluations: one 3 months after the end of the treatment and the other 6 months after. The evaluation will be done using the same battery of tests as during the pre-test interview.
CONDITIONS
Official Title
Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome With or Without Biofeedback
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a diagnosis of Tourette Syndrome or experience bothersome tics
- Be aged 14 to 21 years inclusive at the start of therapy
You will not qualify if you...
- Present a sensorimotor impairment
- Have a diagnosis of intellectual disability (IQ below 75)
- Alcohol or drug abuse
- Have a neurological issue (e.g., hemifacial spasms, Huntington's disease)
- Change medication one month or less before step 1 and up to step 4 without informing the research team
- Receive another intervention for tics simultaneously without informing the research team
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal, Hôpital Rivières-des-Prairies
Montreal, Quebec, Canada, H1E 1A4
Actively Recruiting
Research Team
J
Julie Leclerc, Psychology
CONTACT
A
Audrey-Ann Lachance
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here